Zoetis Inc.
ZTS
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biologicaā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
12 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$127.69
Price-0.15%
-$0.20
1Y
Price
Market Cap
$56.272b
Large
Price/Earnings 3y Avg5y Avg
21.5x
Premium
Premium
Financials Overview
Key metrics over the past few years+44.5%
EBITDA Margin+30.0%
Net Profit Margin+33.5%
Free Cash Flow MarginRevenue
$9.397b
+1.5%
1y CAGR+5.2%
3y CAGR+4.9%
5y CAGREarnings
$2.651b
+6.6%
1y CAGR+7.9%
3y CAGR+6.8%
5y CAGREPS
$5.94
+8.6%
1y CAGR+9.8%
3y CAGR+8.6%
5y CAGRBook Value
$5.398b
$15.159b
Assets$9.761b
Liabilities$7.273b
DebtDebt to Assets
48.0%
1.8x
Debt to EBITDAFree Cash Flow
$2.240b
-2.5%
1y CAGR+20.5%
3y CAGR+9.5%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company